Industry/Academia Translational Oncology Symposium 2012
Moores Cancer Center
Thursday March 22, 2012
-
Welcome and Overview
David Brenner, MD, UC San Diego School of Medicine & Thomas Kipps, MD, PhD, Moores Cancer Center
Topics:
Speakers: David Brenner, Thomas Kipps
Run Time: 15 minutesDavid Brenner is vice chancellor for Health Sciences and dean of the School of Medicine at the University of California, San Diego. In this role, he...
-
Armed with Genomics, Is the Target in Sight for Myelodysplastic Syndromes?
Azra Raza, MD, MDS Center, Columbia University Medical Center
Topics:
Speakers: Azra Raza
Run Time: 23 minutesDr. Raza is the Director of the MDS Center at Columbia University in New York, NY. Dr. Raza completed her medical education in Pakistan, training in...
-
Cilengitide, from Discovery to Clinical Development and Back
David Cheresh, PhD, Moores Cancer Center
Topics:
Speakers: David Cheresh
Run Time: 25 minutesDavid Cheresh studies the mechanism of action of signaling networks that regulate cancer growth and metastasis and focuses on new strategies for...
-
Targeting for Glioblastoma Patients with Cilengitide: Promises and Challenges
David Reardon, MD, Center for Neuro-Oncology, Dana-Farber Cancer Institute
Topics:
Speakers: David Reardon
Run Time: 32 minutesDavid Reardon is clinical director at Dana-Farber Cancer Institute's Center for Neuro-Oncology. His research interests are brain and spinal tumors,...
-
Malignant Progenitor Re-Programming
Catriona Jamieson, MD, PhD, Moores Cancer Center
Topics:
Speakers: Catriona Jamieson
Run Time: 27 minutesCatriona Jamieson, MD, PhD is Associate Professor of Medicine in the Division of Hematology-Oncology and Director for Stem Cell Research at Moores...
-
Phase 1 Dose-Escalation Study of PF-04449913, an Oral Hedgehog Inhibitor, in Patients With Select Hematologic Malignancies
Wendy Levin, Pfizer
Topics:
Speakers: Wendy Levin
Run Time: 16 minutes -
A patient on what it's like to have cancer
Linda Lowe
Topics:
Speakers: Linda Lowe
Run Time: 08 minutes -
Stem Cells and Cancer
Irving Weissman, MD, Stanford School of Medicine
Topics:
Speakers: Irving Weissman
Run Time: 40 minutesIrving L. Weissman's research encompasses the phylogeny and developmental biology of the cells that make up the blood-forming and immune systems. His...
-
PAK Inhibitors for Cancer – Trailblazing a Path to the Clinic
David Campbell, PhD, Afraxis
Topics:
Speakers: David Campbell
Run Time: 14 minutesPrior to Afraxis, Dr. Campbell served as a member of the Phenomix Corporation executive team since 2003, most recently as an executive officer and...
-
The Mouse that ROR'ed – Targeting Onco-Embryonic Antigens
Thomas Kipps, MD, PhD, Moores Cancer Center
Topics:
Speakers: Thomas Kipps
Run Time: 16 minutesThomas Kipps, MD, PhD, is Professor of Medicine, Evelyn and Edwin Tasch Chair in Cancer Research, and Interim Director of the Moores Cancer Center. A...
-
Understanding Rejection (How and Why) through the Melanoma Model
Francesco Marincola, MD, National Institutes of Health
Topics:
Speakers: Francesco Marincola
Run Time: 30 minutesDr. Marincola is Chief of the Infectious Disease and Immunogenetics Section in the Department of Transfusion Medicine at the Clinical Center of the...
-
The New Center for Innovative Therapies: A University-Industry Partnership to Discover and Develop New Treatments and Cures
Marye Anne Fox, PhD, Chancellor, University of California San Diego
Topics:
Speakers: Marye Anne Fox
Run Time: 04 minutesMarye Anne Fox, a world-renowned chemist, is the seventh chancellor of the University of California, San Diego and distinguished professor of...
-
The New Center for Innovative Therapies: A University-Industry Partnership to Discover and Develop New Treatments and Cures
Thomas Kipps, MD, PhD, Moores Cancer Center
Topics:
Speakers: Thomas Kipps
Run Time: 09 minutesThomas Kipps, MD, PhD, is Professor of Medicine, Evelyn and Edwin Tasch Chair in Cancer Research, and Interim Director of the Moores Cancer Center. A...
-
Panel Discussion: Discovery to Therapies…It’s Changing and Quickly
with Duane Roth, Robert Abraham, PhD, Sandra Brown, PhD, Dennis Carson, MD, PhD, David Kabakoff, PhD, Jonathan Thomas, PhD, JD, and Carl Weissman
Topics:
Speakers: Duane Roth, Robert Abraham, Sandra Brown, Dennis Carson, David Kabakoff, Jonathan Thomas, Carl Weissman
Run Time: 1 hours 00 minutesDuane J. Roth is Chief Executive Officer and member of the Board of CONNECT. CONNECT is the globally recognized public benefits organization...
